Literature DB >> 3013291

Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts.

B B Olwin, S D Hauschka.   

Abstract

Two distinct fibroblast growth factors (FGF) were purified to homogeneity from bovine brain on the basis of their ability to stimulate skeletal muscle myoblast proliferation. These growth factors are also mitogenic for Swiss 3T3 cells and appear to be closely related to or identical with previously isolated anionic and cationic fibroblast growth factors. The half-maximum concentrations (EC50) for stimulation of myoblast DNA synthesis by the anionic and cationic growth factors were 30pM and 1pM, respectively. In contrast, an EC50 of 45 pM was observed for stimulation of 3T3 cell DNA synthesis by both growth factors. Binding of 125I-labeled anionic FGF was saturable with apparent Kd values of 45 pM and 11 pM and approximately 60 000 and 2000 receptor sites per cell for 3T3 cells and MM14 murine myoblasts, respectively. Unlabeled anionic and cationic FGF equally displaced 125I-labeled anionic FGF from 3T3 cells while cationic FGF was more potent than anionic FGF for displacement from skeletal muscle myoblasts, demonstrating that a single receptor binds the two distinct growth factors. Binding was specific for these factors since platelet-derived growth factor, insulin, insulin-like growth factor 1, epidermal growth factor, and nerve growth factor were unable to displace bound 125I-labeled anionic FGF from Swiss 3T3 cells. Chemical cross-linking of specifically bound 125I-labeled anionic FGF to 3T3 cells and MM14 myoblasts identified a single detergent-soluble FGF receptor with an apparent molecular weight of 165 000.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013291     DOI: 10.1021/bi00360a001

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  60 in total

1.  Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG).

Authors:  M Ruta; W Burgess; D Givol; J Epstein; N Neiger; J Kaplow; G Crumley; C Dionne; M Jaye; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Heparin-binding growth factors and their receptors.

Authors:  B B Olwin
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

3.  Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells.

Authors:  L Schweigerer; G Neufeld; D Gospodarowicz
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

4.  Effects of basic fibroblast growth factor on bone formation in vitro.

Authors:  E Canalis; M Centrella; T McCarthy
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

5.  Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells.

Authors:  F Bono; P Rigon; I Lamarche; P Savi; V Salel; J M Herbert
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 6.  Basic fibroblast growth factor and its relation to angiogenesis in normal and neoplastic tissue.

Authors:  L Schweigerer
Journal:  Klin Wochenschr       Date:  1988-04-15

7.  Identification of a fibroblast growth factor-binding protein in Drosophila melanogaster.

Authors:  J S Doctor; F M Hoffmann; B B Olwin
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

Review 8.  Autocrine regulation of cell growth and transformation by basic fibroblast growth factor.

Authors:  A Yayon; M Klagsbrun
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

9.  Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0----G1 transition.

Authors:  G Bouche; N Gas; H Prats; V Baldin; J P Tauber; J Teissié; F Amalric
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

10.  Developmental changes in fibroblast growth factor in the chicken embryo limb bud.

Authors:  S I Munaim; M Klagsbrun; B P Toole
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.